Savvy Trades and Investments

[hweb2]

The vitamin sector has definitely not seen the big gains other sectors have during the post-election rally. Other names I follow are flattish to up slightly. The stocks you mentioned probably not enough to gauge the sector. NHTC is a China stock. PRGO more of a drug stock. And I like INBP here, but the pennies just haven't participated. At least not yet.

Not all Borg on NAII, but he is a significant factor as to why the stock is trading at such a depressed price with such strong fundamentals. I've been told by several people that the stock looked undervalued, but they wanted to wait til Borg was out before buying. That should happen within the next few weeks. Then we can look forward to what should be another excellent earnings report in early February. I'm guessing NAII posts fiscal Q2 earnings of .40-.45/share, up 40-60% vs. last year. Q2 revenues should up 25%+. Outlook for the rest of the year should be bullish. Balance sheet will look great, with cash position probably around $3/share. If there's other Nasdaq stocks in the $11's that are set to post such stellar results, I'd like to know about them.